Search results for: 'droplet-microfluidic'

Clinical diagnostics, life science research, genomics and proteomics, and drug discovery labs are adopting lab automation solutions to overcome tremendous operational pressure because of the demand for high throughput and shortage of technicians. Solutions that automate pre-analytical, analytical, and post-analytical processes are available. The re...

This research service covers emerging diagnostic technologies that can transform infectious disease management. CRISPR-based diagnostics: CRISPR (clustered regularly interspaced short palindromic repeats) can deliver rapid, portable and accurate diagnostics tests for field applications. This reports deals with two major US-based players developing...

Nanoemulsions are characterized by high bioavailability and permeability; it can potentially be used to encapsulate both water- and oil-soluble substances. Due to its small droplet size, the encapsulated particles can remain stable for a period of time and can avoid gravitational issues such as Oswald ripening. Due to the abovementioned reasons, t...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease, nephrology, and neurodegenerative disease. It hi...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metabolic disease, rare disorders, neuropsychiatry, and ne...

This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.The study assesses key technology shifts, including rapid molecular testing, lateral flow assays, microfluidics, biosensors, sm...